Developmental Pathway Funding Scheme

Membership from 1 April 2022

  • Professor Simon Hollingsworth (Chair), AstraZeneca
  • Professor Sebastien Ourselin, King’s College London
  • Professor Oliver Bandmann, The University of Sheffield
  • Mrs Pamela Brown, Pam Brown Consulting Ltd
  • Professor Helen Fletcher, London School of Hygiene and Tropical Medicine
  • Professor Tim Harrison, Almac Discovery and Queen’s University Belfast
  • Dr Ranil De Silva, National Heart and Lung Institute, Imperial College
  • Professor Fiona Thistlethwaite, Faculty of Biology, Medicine and Health, The University of Manchester
  • Professor Christopher Scott, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast
  • Dr Nicola Wallis, Astex Pharmaceuticals
  • Professor Giovanni Montana, Warwick Manufacturing Group, University of Warwick
  • Professor Enitan Carrol, Institute of Infection and Global Health, University of Liverpool
  • Dr Hayley Whitaker, University College London
  • Professor Fadi Issa, University of Oxford
  • Professor Divya Maitreyi Chari, Keele University School of Medicine
  • Dr Richard May, Janssen (part of Johnson and Johnson)
  • Professor Francis Drobniewski, Imperial College London
  • Professor Payam Barnaghi, Imperial College London
  • Dr Alice Sitch, University of Birmingham
  • Professor Helen Minnis, University of Glasgow
  • Professor Alan Stitt, Queen’s University Belfast
  • Professor Carl Goodyear, University of Glasgow
  • Professor Zion Tse, Queen Mary University of London
  • Professor Rachel Williams, University of Liverpool
  • Professor Jeremy Brown, University College London

See the Developmental Pathway Funding Scheme conflicts of interest register.

See the funding decision data for this scheme.

Last updated: 23 September 2022

This is the website for UKRI: our seven research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.